Stable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 Weeks

Abstract Background Lebrikizumab demonstrated significant improvement versus placebo for measures of skin clearance and patient-reported outcomes at weeks 16 and 52 in patients with moderate-to-severe atopic dermatitis (AD). We report the sustained impact of lebrikizumab monotherapy, over 52 weeks a...

Full description

Saved in:
Bibliographic Details
Main Authors: Gil Yosipovitch (Author), Peter Lio (Author), Franz J. Legat (Author), Raj Chovatiya (Author), Mette Deleuran (Author), Evangeline Pierce (Author), Marta Casillas (Author), Yuxin Ding (Author), Fan E. Yang (Author), Laia Bardolet (Author), Sonja Ständer (Author)
Format: Book
Published: Adis, Springer Healthcare, 2024-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available